Overexpression of translocator protein in inflammatory bowel disease: Potential diagnostic and treatment value

Inflammatory Bowel Diseases

Volumn 16, Issue 9, 2010, Pages 1476-1487

  Ostuni, Mariano A ^a   Issop, Leeyah ^a   Péranzi, Gabriel ^a   Walker, Francine ^a   Fasseu, Magali ^a   Elbim, Carole ^b,c   Papadopoulos, Vassilios ^d   Lacapere, Jean Jacques ^a  

^a CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Benzodiazepines; Isoquinolines; Peripheral benzodiazepine receptor

Indexed keywords

CARRIER PROTEIN; DEXTRAN SULFATE; FLUNITRAZEPAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; INTESTINE CELL; LIGAND BINDING; MALE; MITOCHONDRION; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE INJURY; TISSUE REGENERATION; TREATMENT INDICATION; ULCERATIVE COLITIS; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZODIAZEPINONES; CARRIER PROTEINS; CASE-CONTROL STUDIES; COLITIS; COLON; COLONIC NEOPLASMS; CYTOKINES; DEXTRAN SULFATE; ENTEROCYTES; FLUNITRAZEPAM; GABA MODULATORS; HUMANS; HYPOLIPIDEMIC AGENTS; IMMUNOENZYME TECHNIQUES; INFLAMMATORY BOWEL DISEASES; ISOQUINOLINES; MALE; MITOCHONDRIA; RATS; RATS, WISTAR; RECEPTORS, GABA; RECEPTORS, GABA-A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77956284907     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21250     Document Type: Article

References (48)

1. Gismera CS, Aladren BS. Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing? World J Gastroenterol. 2008;14:5491-5498.
2. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454:436-444.
3. Rubin DT. The changing face of colorectal cancer in inflammatory bowel disease: progress at last! Gastroenterology. 2006;130:1350-1362
4. Zisman TL, Rubin DT. Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol. 2008;14:2662-2669.
5. Mantovani A. Inflaming metastasis. Nature. 2009;457:36-37.
6. Kim S, Takahashi H, Lin W-W, et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature. 2009;457:102-106.
7. Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27:402-409.
8. Bribes E, Carriere D, Goubet C, et al. Immunohistochemical assessment of the peripheral benzodiazepine receptor in human tissues. J Histochem Cytochem. 2004;52:19-28.
9. Katz Y, Eitan A, Amiri Z, et al. Dramatic increase in peripheral benzodiazepine binding sites in human colonic adenocarcinoma as compared to normal colon. Eur J Pharmacol. 1988;148:483-484.
10. Katz Y, Eitan A, Gavish M. Increase in peripheral benzodiazepine binding sites in colonic adenocarcinoma. Oncology. 1990;47:139-142.
11. Han Z, Slack RS, Li W, et al. Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression. J Recept Signal Transduct Res. 2003;23:225-238.
12. Maaser K, Grabowski P, Oezdem Y, et al. Up-regulation of the peripheral benzodiazepine receptor during human colorectal carcinogenesis and tumor spread. Clin Cancer Res. 2005;11:1751-1756.
13. Maaser K, Grabowski P, Sutter AP, et al. Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer. Clin Cancer Res. 2002;8:3205-3209.
14. Li W, Hardwick MJ, Rosenthal D, et al. Peripheral type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicates its prominent role in tumor cell proliferation. Biochem Pharmacol. 2007;73:491-503.
15. Decaudin D, Castedo M, Nemati F, et al. Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Cancer Res. 2002;62:1388-1393.
16. Bribes E, Bourrie B, Casellas P. Ligands of the peripheral benzodiazepine receptor have therapeutic effects in pneumopathies in vivo. Immunol Lett. 2003;88:241-247.
17. Choi HB, Khoo C, Ryu JK, et al. Inhibition of lipopolysaccharide-induced cyclooxygenase-2, tumor necrosis factor-α and calcium responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195. J Neurochem. 2002;83:546-555.
18. Wirtz S, Neufert C, Weigmann B, et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2:541-546.
19. Brown SJ, Mayer LM. The immune response in inflammatory bowel disease. Am J Gastroenterol. 2007;102:2058-2069.
20. Torres SR, Fröde TS, Nardi GM, et al. Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation. Eur J Pharmacol. 2000;408:199-211.
21. Barbier M, Attoub S, Joubert M, et al. Proinflammatory role of leptin in experimental colitis in rats benefit of cholecystokinin-B antagonist and beta3-agonist. Life Sci. 2001;69:567-580.
22. Ostuni M, Tumilasci OR, Péranzi G, et al. Effect of translocator protein (18-kDa) ligand binding on neurotransmitter-induced saliva secretion in rat submandibular glands. Biol Cell. 2008;100:427-439.
23. Ostuni M, Ducroc R, Peranzi G, et al. Translocator protein (18 kDa) ligand PK11195 induces transient mitochondrial Ca2+ release in HT-29 human colon cancer cells. Biol Cell. 2007;99:639-647.
24. Ostuni M, Marazova K, Peranzi G, et al. PBR ligands mediate chloride current through calcium signaling in rat gastric mucosa. Am J Physiol. 2004;286:G1069-1080.
25. Buyse M, Radeva G, Bado A, et al. Intestinal inflammation induces adaptation of P-glycoprotein expression and activity. Biochem Pharmacol. 2005;69:1745-1754.
26. Kronigsrainer I, Vogel UF, Beckert S, et al. Increased transloctor protein (TSPO) mRNA levels in colon but not in rectum carcinoma. Eur Surg Res. 2007;39:359-363.
27. Galieges S, Tinel N, Casellas P. The peripheral benzodiazepine receptor: a promising therapeutic target. Cur Med Chem. 2003;10:1563-1572.
28. Nayyar T, Mukherjee S, Das SK. Modulation of binding characteristics of peripheral benzodiazepine receptors in vitamin A-deficient guinea pig lung. Biochem Pharmacol. 1996;51:1203-1209.
29. Costa B, Salvetti A, Rossi L, et al. Peripheral benzodiazepine receptor: characterization in human T-lymphoma Jurkat cells. Mol Pharmacol. 2006;69:37-44.
30. Hughes G, Murphy MP, Ledgerwood EC. Mitochondrial reactive oxygen species regulate the temporal factor κB to modulate tumour necrosis factor-induced apoptosis: evidence for mitochondria-targeted antioxidants. Biochem J. 2005;389:83-89.
31. Reed KL, Fruin AB, Gower AC, et al. NF-kappaB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in dextran sulphate sodium-induced colitis in rats. Dig Dis Sci. 2005;50:2366-78.
32. Batarseh A, Giatzakis C, Papadopoulos V. Phorbol-12-myrsitate 13-acetate acting through protein kinase Cå induces translocator protein (18kDa) Tspo gene expression. Biochemistry. 2008;47:12886-12889.
33. Veenman L, Papadopoulos V, Gavish M. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des. 2007;13:2385-2405.
34. Ostuni M, Peranzi G, Ducroc R, et al. Distribution, pharmacological characterization and function of the translocator protein peripheral-type benzodiazepine receptor in rat intestine. Biol Cell. 2009;101:573-586.
35. Lacapère JJ, Delavoie F, Li H, et al. Structural and functional study of reconstituted peripheral benzodiazepine receptor. Biochem Biophys Res Commun. 2001;284:536-541.
36. Garnier M, Dimchev AB, Boujrad N, et al. In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells. Mol Pharmacol. 1994;45:201-211.
37. Papadopoulos V, Berkovich A, Krueger KE, et al. Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology. 1991;129:1481-1488.
38. Galley HF, Dubbels AM, Webster NR. The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesth Analg. 1998;86:1289-1293.
39. Eder C. Mechanisms of interleukin-1b release. Immunobiology. 2009;21:543-553.
40. Obregon C, Rothen-Rutishauser B, Gerber P, et al. Active uptake of dendritic cell-derived exovesicles by epithelial cells induces the release of inflammatory mediators through a TNF-α-mediated pathway. Am J Pathol. 2009;175:696-705.
41. Mustafa A, El-Medany A, Hagar HH, et al. Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis. Pharmacol Res. 2006;53:324-330.
42. Pélissier MA, Muller C, Hill M, et al. Protection against dextran sodium sulfate-induced colitis by dehydroepiandrosterone and 7alpha-hydroxy-dehydroepiandrosterone in the rat. Steroids. 2006;71:240-248.
43. Hennebert O, Pelissier MA, Le Mee S, et al. Anti-inflammatory effects and changes in prostaglandin patterns induced by 7beta-hydroxye-piandrosterone in rats with colitis. J Steroid Biochem Mol Biol. 2008;110:255-262.
44. Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol. 2008;14:348-353.
45. Favreau F, Rossard L, Zhang K, et al. Expression and modulation of translocator protein and its partner by hypoxia reoxygenation or ischemia and reperfusion in porcine renal models. Am J Physiol Renal Physiol. 2009;297:F177-F190.
46. Veenman L, Shandalov Y, Gavish M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J Bioenerg Biomembr. 2008;40:199-205.
47. Kunduzova OR, Escourrou G, De la Farge F, et al. Involvement of peripheral benzodiazepine receptor in the oxidative stress, death-signaling pathway, and renal injury induced by ischemia-reperfusion. J Am Soc Nephrol. 2004;15:2152-2160.
48. Carreras MC, Poderoso JJ. Mitochondrial nitric oxide in the signalling of cell integrated responses. Am J Physiol Cell Physiol. 2007;292:C1569-C1580.